One of the most widely used herbal supplements for improving memory and cognition has no impact on the development of dementia or Alzheimer’s disease, according to new results from a $30 million, multi-center study.
MaxCyte STX scalable transfection system launched in London
Published in November 18th, 2008
Comments Off
MaxCyte, Inc announced today the European launch of the MaxCyte STX Scalable Transfection System at SMi’s Cell-Based Assay Conference held in London, November 19 and 20, 2008.
Protein transporter in the gut could speed drug ‘take up’
Published in November 18th, 2008
Comments Off
For poorly absorbed medications, drug makers should consider using natural homing devices to drive the drugs through the hazards of gastrointestinal acidity and enzymes to reach the bloodstream quicker, James Polli, PhD, said today at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS) in Atlanta.
Mylan receives FDA approval for Fluoxetine capsules
Published in November 18th, 2008
Comments Off
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
Published in November 18th, 2008
Comments Off
Mylan Inc. ( NYSE:MYL ) today announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
New technologies improve supplies of drugs to combat malaria
Published in November 18th, 2008
Comments Off
Three emerging technologies have the potential to significantly improve supplies of drugs to combat malaria, according to a report published today.
Ginkgo proves ineffective in preventing dementia, Alzheimer’s disease
Published in November 18th, 2008
Comments Off
One of the most widely used herbal supplements for improving memory and cognition has no impact on the development of dementia or Alzheimer’s disease, according to new results from a $30 million, multi-center study.
Body’s Nutrient Transporters Could Speed Drug Take Up
Published in November 18th, 2008
Comments Off
For poorly absorbed medications, drug makers should consider using natural homing devices to drive the drugs through the hazards of gastrointestinal acidity and enzymes to reach the bloodstream quicker, James Polli, PhD, said today at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS) in Atlanta.
Arpida Announces Posting of Briefing Documents for FDA Anti-Infective Drugs Advisory Committee Meeting on iclaprim
Published in November 18th, 2008
Comments Off
Arpida (SWX: ARPN) announced today that the U.S. Food and Drug Administration (FDA) has posted on its website briefing documents for the November 20, 2008 Anti-Infective Drugs Advisory Committee (AIDAC) meeting.
Depression, Not SSRIs, Linked to Increased Mortality in Heart-Failure Patients
Published in November 18th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Contrary to recent research suggesting antidepressant use increases mortality in heart-disease patients, a new study suggests that with selective serotonin reuptake inhibitors, this is not the case.
Medscape Medical News